NCT02712905 2025-11-04An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated116 enrolled 36 charts
NCT04282668 2024-12-09A Study of TAS1440 With ATRA in Subjects With r/r AMLTaiho Oncology, Inc.Phase 1 Terminated52 enrolled